FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DSN4

Real-time Bid/Ask 10:11:15 2024-07-03 am EDT
12.7 EUR / 13 EUR +3.21% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-12.26%
1 month-48.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 12.5 +0.40%
24-07-02 12.45 -3.64%
24-07-01 12.92 -8.95%
24-06-28 14.19 +4.72%
24-06-27 13.55 +2.42%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 06:52 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DSN
ISINDE000JK5DSN4
Date issued 2024-03-22
Strike 19.58 $
Maturity Unlimited
Parity 1.5 : 1
Emission price 10.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24
Lowest since issue 8.78
Spread 0.3
Spread %2.31%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
39.15 USD
Average target price
49.93 USD
Spread / Average Target
+27.54%
Consensus